HomeNDC LookupIngredients › Adagrasib
📦 NDC / package directory — not a drug information page

Adagrasib NDCs, Package Codes, Strengths & Labelers

This page lists NDC package records for Adagrasib products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.

Looking for uses, warnings & side effects? Read our Adagrasib drug information page →

Key stats

7
Package NDCs
6
Products
6
Active listings
0
Discontinued
6
Labelers
2
Strengths
2
Dosage forms
0
With NADAC pricing

By strength, form & labeler

NDC products by strength
ADAGRASIB 200 mg/1 3
ADAGRASIB 1 kg/kg 3
By dosage form
TABLET, COATED 3
POWDER 3
Top labelers
Asymchem Laboratories (Tianjin) Co... 1
Mirati Therapeutics, Inc 1
MSN Laboratories Private Limited 1
PATHEON FRANCE S.A.S 1
Patheon, Inc. 1
Syngene International Limited 1

Browse records — 6 products

Drug / product Billing NDC NADAC / unit Status
adagrasib 200 mg/1 TABLET, COATED Patheon, · NDC 63285-0894-00 · 14423 TABLET, COATED in 1 DRUM (63285-894-00) 63285-0894-00 On market View →
Adagrasib 1 kg/kg POWDER Asymchem · NDC 72015-0006-01 · 1 BAG in 1 DRUM (72015-006-01) / 15 kg in 1 BAG 72015-0006-01 On market View →
Adagrasib 200 mg/1 TABLET, COATED PATHEON · NDC 47049-0043-00 · 12800 TABLET, COATED in 1 DRUM (47049-043-00) 47049-0043-00 On market View →
Adagrasib 1 kg/kg POWDER Syngene · NDC 84101-0003-01 · 20 kg in 1 DRUM (84101-003-01) 84101-0003-01 On market View →
Adagrasib 1 kg/kg POWDER MSN · NDC 54893-0525-01 · 15 kg in 1 DRUM (54893-0525-1) 54893-0525-01 On market View →
KRAZATI adagrasib 200 mg/1 TABLET, COATED Mirati · NDC 80739-0812-12 · 1 BOTTLE in 1 CARTON (80739-812-12) / 120 TABLET, COATED in 1 BOTTLE 80739-0812-12 On market View →
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.